Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 583

1.

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

Psychosom Med. 1997 May-Jun;59(3):241-50.

PMID:
9178335
2.

The course of major depression in diabetes.

Lustman PJ, Griffith LS, Freedland KE, Clouse RE.

Gen Hosp Psychiatry. 1997 Mar;19(2):138-43.

PMID:
9097068
3.

Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.

Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

Diabetes Care. 1995 Aug;18(8):1133-9.

PMID:
7587848
4.

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.

Lustman PJ, Freedland KE, Griffith LS, Clouse RE.

Diabetes Care. 2000 May;23(5):618-23.

5.

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial.

Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE.

Ann Intern Med. 1998 Oct 15;129(8):613-21.

PMID:
9786808
6.
7.

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.

Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, Begley AE, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 2001 Aug;62(8):597-604.

PMID:
11561930
8.

Depressed mood is a factor in glycemic control in type 1 diabetes.

Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, Surwit RS.

Psychosom Med. 2001 Jul-Aug;63(4):551-5.

PMID:
11485108
9.

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.

Akhondzadeh S, Faraji H, Sadeghi M, Afkham K, Fakhrzadeh H, Kamalipour A.

J Clin Pharm Ther. 2003 Oct;28(5):379-84.

PMID:
14632962
10.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

Arch Gen Psychiatry. 2006 May;63(5):521-9.

PMID:
16651509
12.

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

Clin Ther. 2003 Apr;25(4):1074-95.

PMID:
12809958
13.

Changes in depressive symptoms and glycemic control in diabetes mellitus.

Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS.

Psychosom Med. 2007 Apr;69(3):235-41. Epub 2007 Apr 9.

PMID:
17420441
14.

A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain.

Atkinson JH, Slater MA, Williams RA, Zisook S, Patterson TL, Grant I, Wahlgren DR, Abramson I, Garfin SR.

Pain. 1998 Jun;76(3):287-96.

PMID:
9718247
15.

Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus.

de Groot M, Jacobson AM, Samson JA, Welch G.

J Psychosom Res. 1999 May;46(5):425-35.

PMID:
10404477
16.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
17.

The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study.

Chemerinski E, Robinson RG, Arndt S, Kosier JT.

J Nerv Ment Dis. 2001 Jul;189(7):421-5.

PMID:
11504318
18.

Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control.

Dirmaier J, Watzke B, Koch U, Schulz H, Lehnert H, Pieper L, Wittchen HU.

Psychother Psychosom. 2010;79(3):172-8. doi: 10.1159/000296135. Epub 2010 Mar 17.

PMID:
20234147
19.

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.

Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T.

Arch Gen Psychiatry. 2004 Oct;61(10):1042-9.

PMID:
15466678
20.

Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.

Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR.

Clin Ther. 2008 Jun;30(6):1081-8. doi: 10.1016/j.clinthera.2008.05.021.

PMID:
18640464

Supplemental Content

Support Center